Brain : a journal of neurology最新文献

{"title":"Repetitive TMS applied to the precuneus stabilizes cognitive status in Alzheimer's disease.","authors":"Zahra Moussavi","doi":"10.1093/brain/awac322","DOIUrl":"https://doi.org/10.1093/brain/awac322","url":null,"abstract":"This scientific commentary refers to ‘Precuneus magnetic stimulation for Alzheimer's disease: a randomized, sham-controlled trial’ by Koch et al. (https://doi.org/10.1093/brain/awac285).","PeriodicalId":121505,"journal":{"name":"Brain : a journal of neurology","volume":" ","pages":"3730-3732"},"PeriodicalIF":14.5,"publicationDate":"2022-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40700341","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Expedited epilepsy surgery prior to drug resistance in children: a frontier worth crossing?","authors":"Andrew T Hale,&nbsp;Aswin Chari,&nbsp;Rod C Scott,&nbsp;J Helen Cross,&nbsp;Curtis J Rozzelle,&nbsp;Jeffrey P Blount,&nbsp;Martin M Tisdall","doi":"10.1093/brain/awac275","DOIUrl":"https://doi.org/10.1093/brain/awac275","url":null,"abstract":"<p><p>Epilepsy surgery is an established safe and effective treatment for selected candidates with drug-resistant epilepsy. In this opinion piece, we outline the clinical and experimental evidence for selectively considering epilepsy surgery prior to drug resistance. Our rationale for expedited surgery is based on the observations that (i) a high proportion of patients with lesional epilepsies (e.g. focal cortical dysplasia, epilepsy-associated tumours) will progress to drug resistance; (ii) surgical treatment of these lesions, especially in non-eloquent areas of brain, is safe; and (iii) earlier surgery may be associated with better seizure outcomes. Potential benefits beyond seizure reduction or elimination include less exposure to antiseizure medications, which may lead to improved developmental trajectories in children and optimize long-term neurocognitive outcomes and quality of life. Further, there exists emerging experimental evidence that brain network dysfunction exists at the onset of epilepsy, where continuing dysfunctional activity could exacerbate network perturbations. This in turn could lead to expanded seizure foci and contribution to the comorbidities associated with epilepsy. Taken together, we rationalize that epilepsy surgery, in carefully selected cases, may be considered prior to drug resistance. Last, we outline the path forward, including the challenges associated with developing the evidence base and implementing this paradigm into clinical care.</p>","PeriodicalId":121505,"journal":{"name":"Brain : a journal of neurology","volume":" ","pages":"3755-3762"},"PeriodicalIF":14.5,"publicationDate":"2022-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40539720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"How does foetal exposure to valproate produce adverse neurodevelopmental outcomes?","authors":"Kimford J Meador,&nbsp;Yi Li","doi":"10.1093/brain/awac374","DOIUrl":"https://doi.org/10.1093/brain/awac374","url":null,"abstract":"","PeriodicalId":121505,"journal":{"name":"Brain : a journal of neurology","volume":" ","pages":"3733-3734"},"PeriodicalIF":14.5,"publicationDate":"2022-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33500204","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The spectrum of complement pathway activation is integral to the pathogenesis of severe COVID-19.","authors":"Cynthia Magro,&nbsp;Gerard Nuovo","doi":"10.1093/brain/awac311","DOIUrl":"https://doi.org/10.1093/brain/awac311","url":null,"abstract":"","PeriodicalId":121505,"journal":{"name":"Brain : a journal of neurology","volume":" ","pages":"e115-e117"},"PeriodicalIF":14.5,"publicationDate":"2022-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40464136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Associating Alzheimer's disease pathology with its cerebrospinal fluid biomarkers.","authors":"Claire Bridel,&nbsp;Charisse Somers,&nbsp;Anne Sieben,&nbsp;Annemieke Rozemuller,&nbsp;Ellis Niemantsverdriet,&nbsp;Hanne Struyfs,&nbsp;Yannick Vermeiren,&nbsp;Christine Van Broeckhoven,&nbsp;Peter P De Deyn,&nbsp;Maria Bjerke,&nbsp;Guy Nagels,&nbsp;Charlotte E Teunissen,&nbsp;Sebastiaan Engelborghs","doi":"10.1093/brain/awac013","DOIUrl":"https://doi.org/10.1093/brain/awac013","url":null,"abstract":"<p><p>Alzheimer's disease CSF biomarkers 42 amino acid long amyloid-β peptide (Aβ1-42), total tau protein (T-tau), and tau protein phosphorylated at threonine 181 (P-tau181) are considered surrogate biomarkers of Alzheimer's disease pathology, and significantly improve diagnostic accuracy. Their ability to reflect neuropathological changes later in the disease course is not well characterized. This study aimed to assess the potential of CSF biomarkers measured in mid to late stage Alzheimer's disease to reflect post-mortem neuropathological changes. Individuals were selected from two autopsy cohorts of Alzheimer's disease patients in Antwerp and Amsterdam. Neuropathological diagnosis was performed according to the updated consensus National Institute on Aging-Alzheimer's Association guidelines, which includes quantification of amyloid-β plaque, neurofibrillary tangle, and neuritic plaque load. CSF samples were analysed for Aβ1-42, T-tau, and P-tau181 by ELISA. One hundred and fourteen cases of pure definite Alzheimer's disease were included in the study (mean age 74 years, disease duration 6 years at CSF sampling, 50% females). Median interval between CSF sampling and death was 1 year. We found no association between Aβ1-42 and Alzheimer's disease neuropathological change profile. In contrast, an association of P-tau181 and T-tau with Alzheimer's disease neuropathological change profile was observed. P-tau181 was associated with all three individual Montine scores, and the associations became stronger and more significant as the interval between lumbar puncture and death increased. T-tau was also associated with all three Montine scores, but in individuals with longer intervals from lumbar puncture to death only. Stratification of the cohort according to APOE ε4 carrier status revealed that the associations applied mostly to APOE ε4 non-carriers. Our data suggest that similar to what has been reported for Aβ1-42, plateau levels of P-tau181 and T-tau are reached during the disease course, albeit at later disease stages, reducing the potential of tau biomarkers to monitor Alzheimer's disease pathology as the disease progresses. As a consequence, CSF biomarkers, which are performant for clinical diagnosis of early Alzheimer's disease, may not be well suited for staging or monitoring Alzheimer's disease pathology as it progresses through later stages.</p>","PeriodicalId":121505,"journal":{"name":"Brain : a journal of neurology","volume":" ","pages":"4056-4064"},"PeriodicalIF":14.5,"publicationDate":"2022-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39695194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Precuneus magnetic stimulation for Alzheimer's disease: a randomized, sham-controlled trial.","authors":"Giacomo Koch,&nbsp;Elias Paolo Casula,&nbsp;Sonia Bonnì,&nbsp;Ilaria Borghi,&nbsp;Martina Assogna,&nbsp;Marilena Minei,&nbsp;Maria Concetta Pellicciari,&nbsp;Caterina Motta,&nbsp;Alessia D'Acunto,&nbsp;Francesco Porrazzini,&nbsp;Michele Maiella,&nbsp;Clarissa Ferrari,&nbsp;Carlo Caltagirone,&nbsp;Emiliano Santarnecchi,&nbsp;Marco Bozzali,&nbsp;Alessandro Martorana","doi":"10.1093/brain/awac285","DOIUrl":"https://doi.org/10.1093/brain/awac285","url":null,"abstract":"<p><p>Repetitive transcranial magnetic stimulation (rTMS) is emerging as a non-invasive therapeutic strategy in the battle against Alzheimer's disease. Alzheimer's disease patients primarily show alterations of the default mode network for which the precuneus is a key node. Here, we hypothesized that targeting the precuneus with TMS represents a promising strategy to slow down cognitive and functional decline in Alzheimer's disease patients. We performed a randomized, double-blind, sham-controlled, phase 2, 24-week trial to determine the safety and efficacy of precuneus stimulation in patients with mild-to-moderate Alzheimer's disease. Fifty Alzheimer's disease patients were randomly assigned in a 1:1 ratio to either receive precuneus or sham rTMS (mean age 73.7 years; 52% female). The trial included a 24-week treatment, with a 2-week intensive course in which rTMS (or sham) was applied daily five times per week, followed by a 22-week maintenance phase in which stimulation was applied once weekly. The Clinical Dementia Rating Scale-Sum of Boxes was selected as the primary outcome measure, in which post-treatment scores were compared to baseline. Secondary outcomes included score changes in the Alzheimer's Disease Assessment Scale-Cognitive Subscale, Mini-Mental State Examination and Alzheimer's Disease Cooperative Study-Activities of Daily Living scale. Moreover, single-pulse TMS in combination with EEG was used to assess neurophysiological changes in precuneus cortical excitability and oscillatory activity. Our findings show that patients that received precuneus repetitive magnetic stimulation presented a stable performance of the Clinical Dementia Rating Scale-Sum of Boxes score, whereas patients treated with sham showed a worsening of their score. Compared with the sham stimulation, patients in the precuneus stimulation group also showed also significantly better performances for the secondary outcome measures, including the Alzheimer's Disease Assessment Scale-Cognitive Subscale, Mini-Mental State Examination and Alzheimer's Disease Cooperative Study-Activities of Daily Living scale. Neurophysiological results showed that precuneus cortical excitability remained unchanged after 24 weeks in the precuneus stimulation group, whereas it was significantly reduced in the sham group. Finally, we found an enhancement of local gamma oscillations in the group treated with precuneus stimulation but not in patients treated with sham. We conclude that 24 weeks of precuneus rTMS may slow down cognitive and functional decline in Alzheimer's disease. Repetitive TMS targeting the default mode network could represent a novel therapeutic approach in Alzheimer's disease patients.</p>","PeriodicalId":121505,"journal":{"name":"Brain : a journal of neurology","volume":" ","pages":"3776-3786"},"PeriodicalIF":14.5,"publicationDate":"2022-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/2a/5a/awac285.PMC9679166.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40570811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Inflammatory brain injury after severe viral infection is not unique to COVID-19.","authors":"Angelika Bauer,&nbsp;Markus Reindl","doi":"10.1093/brain/awac368","DOIUrl":"https://doi.org/10.1093/brain/awac368","url":null,"abstract":"This scientific commentary refers to ‘Brain injury in COVID-19 is associated with dysregulated innate and adaptive immune responses’ by Needham et al. (https://doi.org/10.1093/brain/awac321).","PeriodicalId":121505,"journal":{"name":"Brain : a journal of neurology","volume":" ","pages":"3738-3740"},"PeriodicalIF":14.5,"publicationDate":"2022-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ff/6f/awac368.PMC9619619.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33489356","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Notes on establishing fear conditioning as causal in the postural orthostatic tachycardia syndrome.","authors":"Roald A Lambrechts,&nbsp;Bram Jacobs","doi":"10.1093/brain/awac346","DOIUrl":"https://doi.org/10.1093/brain/awac346","url":null,"abstract":"","PeriodicalId":121505,"journal":{"name":"Brain : a journal of neurology","volume":" ","pages":"e107-e108"},"PeriodicalIF":14.5,"publicationDate":"2022-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33480331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The human cognition-enhancing CORD7 mutation increases active zone number and synaptic release.","authors":"Mila M Paul,&nbsp;Sven Dannhäuser,&nbsp;Lydia Morris,&nbsp;Achmed Mrestani,&nbsp;Martha Hübsch,&nbsp;Jennifer Gehring,&nbsp;Georgios N Hatzopoulos,&nbsp;Martin Pauli,&nbsp;Genevieve M Auger,&nbsp;Grit Bornschein,&nbsp;Nicole Scholz,&nbsp;Dmitrij Ljaschenko,&nbsp;Martin Müller,&nbsp;Markus Sauer,&nbsp;Hartmut Schmidt,&nbsp;Robert J Kittel,&nbsp;Aaron DiAntonio,&nbsp;Ioannis Vakonakis,&nbsp;Manfred Heckmann,&nbsp;Tobias Langenhan","doi":"10.1093/brain/awac011","DOIUrl":"https://doi.org/10.1093/brain/awac011","url":null,"abstract":"<p><p>Humans carrying the CORD7 (cone-rod dystrophy 7) mutation possess increased verbal IQ and working memory. This autosomal dominant syndrome is caused by the single-amino acid R844H exchange (human numbering) located in the 310 helix of the C2A domain of RIMS1/RIM1 (Rab3-interacting molecule 1). RIM is an evolutionarily conserved multi-domain protein and essential component of presynaptic active zones, which is centrally involved in fast, Ca2+-triggered neurotransmitter release. How the CORD7 mutation affects synaptic function has remained unclear thus far. Here, we established Drosophila melanogaster as a disease model for clarifying the effects of the CORD7 mutation on RIM function and synaptic vesicle release. To this end, using protein expression and X-ray crystallography, we solved the molecular structure of the Drosophila C2A domain at 1.92 Å resolution and by comparison to its mammalian homologue ascertained that the location of the CORD7 mutation is structurally conserved in fly RIM. Further, CRISPR/Cas9-assisted genomic engineering was employed for the generation of rim alleles encoding the R915H CORD7 exchange or R915E, R916E substitutions (fly numbering) to effect local charge reversal at the 310 helix. Through electrophysiological characterization by two-electrode voltage clamp and focal recordings we determined that the CORD7 mutation exerts a semi-dominant rather than a dominant effect on synaptic transmission resulting in faster, more efficient synaptic release and increased size of the readily releasable pool but decreased sensitivity for the fast calcium chelator BAPTA. In addition, the rim CORD7 allele increased the number of presynaptic active zones but left their nanoscopic organization unperturbed as revealed by super-resolution microscopy of the presynaptic scaffold protein Bruchpilot/ELKS/CAST. We conclude that the CORD7 mutation leads to tighter release coupling, an increased readily releasable pool size and more release sites thereby promoting more efficient synaptic transmitter release. These results strongly suggest that similar mechanisms may underlie the CORD7 disease phenotype in patients and that enhanced synaptic transmission may contribute to their increased cognitive abilities.</p>","PeriodicalId":121505,"journal":{"name":"Brain : a journal of neurology","volume":" ","pages":"3787-3802"},"PeriodicalIF":14.5,"publicationDate":"2022-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39815562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Methodological drawbacks in the alleged association between foetal sonographic anomalies and autism.","authors":"Lena Sagi-Dain,&nbsp;Boaz Weisz,&nbsp;Karina Haratz Krajden,&nbsp;Amihood Singer,&nbsp;Yuval Yaron,&nbsp;Ron Maymon","doi":"10.1093/brain/awac246","DOIUrl":"https://doi.org/10.1093/brain/awac246","url":null,"abstract":"","PeriodicalId":121505,"journal":{"name":"Brain : a journal of neurology","volume":" ","pages":"e90-e91"},"PeriodicalIF":14.5,"publicationDate":"2022-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40481676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}